ExpreS2ion Biotech Holding AB (EXPRS2)
Market Closed
15 Oct, 03:25 PM
XSTO XSTO Primary XSTO kr
1. 03
0
0%
kr
- Market Cap
- P/E Ratio
- Div Yield
292,957 Volume
- Eps
kr 1.03
Previous Close Want to track EXPRS2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ExpreS2ion Biotech Holding AB (EXPRS2) Statistics
Valuation metrics
Market Cap -
Enterprise value -30.15M
Trailing P/E (ttm) -0.16
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.72
Price/Book (mrq) 0.94
Enterprise Value/Revenue -7.86
Enterprise Value/EBITDA 0.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 78.49K
Average volume (90 days) 111.84K
Price summary
52-Week low 1.65
52-Week high 28.55
Beta -
50-Day moving average 1.24
200-Day moving average 1.97
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:40
Last split Date 30 Oct 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.36%
Operating margin -16.74%
Operational effectiveness
Return on assets -0.62%
Return on equity -1.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.95
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 3.38%
Book value per share (mrq) 1.16
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
